Comment from Center for Biological Diversity
AnonymousOpposeAdvocacy
Summary: The Center for Biological Diversity opposes the citizen petition seeking to restrict the FDA's regulation of mifepristone. They argue that the petition lacks a legal or factual basis, misrepresents environmental laws, and relies on ideological concerns rather than scientific evidence regarding water contamination.
See attached file(s)